Summary
AbbVie Inc. (ABBV) filed an 8-K on November 12, 2020, announcing a significant leadership transition. Carlos Alban, Vice Chairman and Chief Commercial Officer, will retire at the end of the first quarter of 2021, concluding a 34-year career with the company. This departure marks the end of an era for a long-standing executive who has played a key role in AbbVie's commercial operations.
Key Highlights
- 1Carlos Alban, AbbVie's Vice Chairman and Chief Commercial Officer, announced his retirement, effective at the end of Q1 2021.
- 2Mr. Alban has had a 34-year career with the company.
- 3Jeffrey R. Stewart will succeed Mr. Alban as Executive Vice President, Commercial Operations.
- 4Mr. Stewart currently serves as Senior Vice President, U.S. Commercial Operations.
- 5The filing formally announces a planned leadership change in a critical commercial role.
Frequently Asked Questions
Carlos Alban is retiring after a 34-year career with AbbVie, having informed the company of his decision to retire effective at the end of the first quarter of 2021.
Jeffrey R. Stewart, currently Senior Vice President of U.S. Commercial Operations, will succeed Mr. Alban as Executive Vice President, Commercial Operations.
The retirement of Carlos Alban and the succession of Jeffrey R. Stewart are scheduled to take effect at the end of the first quarter of 2021.